Table 1.
Patient Characteristics | |
---|---|
N | 15 |
n eligible | 14 |
n evaluable | 13 |
Median age at enrollment, y (range) | 9.7 (3–19.5) |
Histology | Grade II = 10, grade III = 4 |
n on EIACD | 2 |
Median no. of courses (range) | 3 (2–12) |
Objective responses (CR + PR) | 0 |
n cases stable disease for >12 weeks | 2 |
n cases progressive disease | 10 |
Median time to progression (range) | 2.2 mo (1.9–6.3) |
6-mo PFS (±SE) | 25.7% (±11.1%) |